In ulcerative colitis, what risk is associated with excessive use of diphenoxylate (Lomotil)?

Prepare for the HESI Inflammatory Bowel Disease Exam. Utilize flashcards and multiple-choice questions, each with hints and explanations. Set yourself up for success!

Multiple Choice

In ulcerative colitis, what risk is associated with excessive use of diphenoxylate (Lomotil)?

Explanation:
In ulcerative colitis, using diphenoxylate (Lomotil) excessively can dangerously slow the bowel and allow the colon to become massively distended. Diphenoxylate is an opioid-like antidiarrheal that reduces intestinal motility; in an inflamed colon, this can lead to gas and stool buildup, resulting in toxic megacolon, a life-threatening dilation of the colon with systemic toxicity. This scenario is the main risk because it directly stems from suppressing colonic movement in a diseased colon, whereas dehydration is a broader consequence of diarrhea and seizures aren’t a typical risk with standard use. Appendicitis isn’t linked to this medication, so it doesn’t fit the specific danger posed by overuse in ulcerative colitis.

In ulcerative colitis, using diphenoxylate (Lomotil) excessively can dangerously slow the bowel and allow the colon to become massively distended. Diphenoxylate is an opioid-like antidiarrheal that reduces intestinal motility; in an inflamed colon, this can lead to gas and stool buildup, resulting in toxic megacolon, a life-threatening dilation of the colon with systemic toxicity. This scenario is the main risk because it directly stems from suppressing colonic movement in a diseased colon, whereas dehydration is a broader consequence of diarrhea and seizures aren’t a typical risk with standard use. Appendicitis isn’t linked to this medication, so it doesn’t fit the specific danger posed by overuse in ulcerative colitis.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy